Nathan Horner

Founder / CEO of NICTAVI LLC, Patent holding Inventor, Artist,
Summary
Nathan Horner is the Founder and CEO of Nictavi LLC, an innovative ophthalmic medical device startup specializing in eyelid closure solutions.
He is a CTIP portfolio member and has received the 2020 CTIP Catalyzing Innovation in Pediatrics Grant.
Nathan Horner is a 2020-21 graduate of the Global Eye Entrepreneurs Fellowship, dedicated to fostering entrepreneurship in the ophthalmic industry.
Nictavi's flagship product, the Tarsus Eyelid Patch, is an FDA-listed Class 1, 510k exempt medical device designed to maintain eyelid closure for therapeutic purposes, reducing infection risks and encouraging healing.
The Tarsus Eyelid Patch offers a user-friendly approach to eyelid closure therapy, ensuring easy application and residue-free removal.
Nathan Horner's mission is to revolutionize the treatment and therapy of eye and eyelid health issues to enhance quality of life and reduce suffering.
Nictavi boasts intellectual property rights, including patents on device and method, trademarks for the Nictavi brand, and international trademark protections in key markets like China and India.
Nathan Horner's educational background includes studies in Painting, Graphic Design, Typography, and Entrepreneurship, with certifications from renowned institutions like Virginia Commonwealth University and Pasadena City College.
As the sole Founder of Nictavi LLC, Nathan Horner leads a team dedicated to transforming eye care through innovative and user-centric solutions.